128 related articles for article (PubMed ID: 32488882)
1. Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.
Yan Y; Xu J; Xu B; Wen Q; Zhou J; Zhang L; Zuo L; Lv G; Shi Y
J Clin Lab Anal; 2020 Sep; 34(9):e23403. PubMed ID: 32488882
[TBL] [Abstract][Full Text] [Related]
2. XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.
Qin F; Gao SL; Xu K; Su QX; Zhang Z; Shi L; Zhu LJ; Zhang LF; Zuo L
Medicine (Baltimore); 2020 Jul; 99(28):e21160. PubMed ID: 32664151
[TBL] [Abstract][Full Text] [Related]
3. Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.
Zou YF; Tao JH; Ye QL; Pan HF; Pan FM; Su H; Ye DQ
Genet Test Mol Biomarkers; 2013 Dec; 17(12):926-31. PubMed ID: 24093803
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in XPC gene and risk for prostate cancer.
Said R; Bougatef K; Setti Boubaker N; Jenni R; Derouiche A; Chebil M; Ouerhani S
Mol Biol Rep; 2019 Feb; 46(1):1117-1125. PubMed ID: 30552616
[TBL] [Abstract][Full Text] [Related]
5. XPC as breast cancer susceptibility gene: evidence from genetic profiling, statistical inferences and protein structural analysis.
Malik SS; Zia A; Rashid S; Mubarik S; Masood N; Hussain M; Yasmin A; Bano R
Breast Cancer; 2020 Nov; 27(6):1168-1176. PubMed ID: 32562189
[TBL] [Abstract][Full Text] [Related]
6. DNA repair gene X-ray repair cross-complementing group 1 and xeroderma pigmentosum group D polymorphisms and risk of prostate cancer: a study from North India.
Mandal RK; Gangwar R; Mandhani A; Mittal RD
DNA Cell Biol; 2010 Apr; 29(4):183-90. PubMed ID: 20070155
[TBL] [Abstract][Full Text] [Related]
7. Modulation of risk of squamous cell carcinoma head and neck in North Indian population with polymorphisms in xeroderma pigmentosum complementation Group C gene.
Yadav SK; Singh S; Gupta S; Brahma Bhatt ML; Mishra DP; Roy D; Sanyal S
J Cancer Res Ther; 2018; 14(3):651-657. PubMed ID: 29893334
[TBL] [Abstract][Full Text] [Related]
8. Association of XPC Gene Polymorphisms with Prostate Cancer Risk.
Kahnamouei SA; Narouie B; Sotoudeh M; Mollakouchekian MJ; Simforoosh N; Ziaee SA; Samzadeh M; Afshari M; Jamaldini SH; Imeni M; Hasanzad M
Clin Lab; 2016; 62(6):1009-15. PubMed ID: 27468562
[TBL] [Abstract][Full Text] [Related]
9. Poly (AT) deletion/insertion polymorphism of the XPC gene contributes to urinary system cancer susceptibility: a meta-analysis.
Dai QS; Hua RX; Zhang R; Huang YS; Hua ZM; Yun CT; Zeng RF; Long JT
Gene; 2013 Oct; 528(2):335-42. PubMed ID: 23892089
[TBL] [Abstract][Full Text] [Related]
10. Lack of association between XPC Lys939Gln polymorphism and prostate cancer risk: an updated meta-analysis based on 3039 cases and 3253 controls.
Wu H; Lv Z; Wang X; Zhang L; Mo N
Int J Clin Exp Med; 2015; 8(10):17959-67. PubMed ID: 26770390
[TBL] [Abstract][Full Text] [Related]
11. XPC intron11 C/A polymorphism as a risk factor for prostate cancer.
Yoshino Y; Takeuchi S; Katoh T; Kuroda Y
Environ Health Prev Med; 2016 Mar; 21(2):100-4. PubMed ID: 26745975
[TBL] [Abstract][Full Text] [Related]
12. Poly (AT) polymorphism in the XPC gene and smoking enhance the risk of prostate cancer in a low-risk Chinese population.
Liu Y; Chen Z; Wei Q; Yuan F; Zhi Y; Song B; Yang J
Cancer Genet; 2012 May; 205(5):205-11. PubMed ID: 22682619
[TBL] [Abstract][Full Text] [Related]
13. Associations between polymorphisms of the XPC gene and lung cancer susceptibility: a meta-analysis.
Zhu ML; Hua RX; Zheng L
Tumour Biol; 2014 Apr; 35(4):2931-9. PubMed ID: 24375193
[TBL] [Abstract][Full Text] [Related]
14. A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.
Chen Y; Zhong H; Gao JG; Tang JE; Wang R
Urol J; 2015 Jul; 12(3):2138-47. PubMed ID: 26135929
[TBL] [Abstract][Full Text] [Related]
15. XPC Polymorphism and Risk for Lung Cancer in North Indian Patients Treated with Platinum Based Chemotherapy and Its Association with Clinical Outcomes.
Lawania S; Singh N; Behera D; Sharma S
Pathol Oncol Res; 2018 Apr; 24(2):353-366. PubMed ID: 28540485
[TBL] [Abstract][Full Text] [Related]
16. Polymorphisms in nucleotide excision repair genes and risk of primary prostate cancer in Chinese Han populations.
Wang M; Li Q; Gu C; Zhu Y; Yang Y; Wang J; Jin L; He J; Ye D; Wei Q
Oncotarget; 2017 Apr; 8(15):24362-24371. PubMed ID: 27974699
[TBL] [Abstract][Full Text] [Related]
17. CDKN1B Val 109 Gly variant is not related to risk of prostate cancer.
Zhu L; Wang J; Yue C; Yuan W; Zhang W; Shi L; Mi Y; Wu X; Zhang LF; Zuo L
J Cell Biochem; 2019 Oct; 120(10):18346-18356. PubMed ID: 31257659
[TBL] [Abstract][Full Text] [Related]
18. Association of XPC Polymorphisms with Cutaneous Malignant Melanoma Risk: Evidence from a Meta-Analysis.
Asadian F; Niktabar SM; Ghelmani Y; Kargar S; Akbarian E; Emarati SA; Sadeghizadeh-Yazdi J; Neamatzadeh H
Acta Medica (Hradec Kralove); 2020; 63(3):101-112. PubMed ID: 33002396
[TBL] [Abstract][Full Text] [Related]
19. Associations of Lys939Gln and Ala499Val polymorphisms of the XPC gene with cancer susceptibility: a meta-analysis.
He J; Shi TY; Zhu ML; Wang MY; Li QX; Wei QY
Int J Cancer; 2013 Oct; 133(8):1765-75. PubMed ID: 23400628
[TBL] [Abstract][Full Text] [Related]
20. An association between XPC Lys939Gln polymorphism and the risk of bladder cancer: a meta-analysis.
Zhang Y; Wang X; Zhang W; Gong S
Tumour Biol; 2013 Apr; 34(2):973-82. PubMed ID: 23269608
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
